COR Stock Chart & Stats
$5413.67
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$4,434.00 - $6,940.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)24.00
Market Cap
$1.05T
Enterprise Value$71.71K
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$12.39B
Price to Earnings (P/E)23.6
Beta0.24
Next Earnings
Aug 05, 2026EPS Estimate
76.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.12
Shares OutstandingN/A
10 Day Avg. Volume72
30 Day Avg. Volume24
Financial Highlights & Ratios
PEG Ratio7.05
Price to Book (P/B)40.17
Price to Sales (P/S)0.19
P/FCF Ratio18.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6,106.69Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
COR FAQ
What was Cencora, Inc.’s price range in the past 12 months?
Cencora, Inc. lowest stock price was $4434.00 and its highest was $6940.20 in the past 12 months.
What is Cencora, Inc.’s market cap?
Cencora, Inc.’s market cap is $1.05T.
When is Cencora, Inc.’s upcoming earnings report date?
Cencora, Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 10 days.
How were Cencora, Inc.’s earnings last quarter?
Cencora, Inc. released its earnings results on May 06, 2026. The company reported $83.167 earnings per share for the quarter, missing the consensus estimate of $84.358 by -$1.191.
Is Cencora, Inc. overvalued?
According to Wall Street analysts Cencora, Inc.’s price is currently Undervalued.
Does Cencora, Inc. pay dividends?
Cencora, Inc. does not currently pay dividends.
What is Cencora, Inc.’s EPS estimate?
Cencora, Inc.’s EPS estimate is 76.11.
How many shares outstanding does Cencora, Inc. have?
Currently, no data Available
What happened to Cencora, Inc.’s price movement after its last earnings report?
Cencora, Inc. reported an EPS of $83.167 in its last earnings report, missing expectations of $84.358. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cencora, Inc.?
Currently, no hedge funds are holding shares in MX:COR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cencora Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6,106.69 (― Downside)
$6,106.69 (― Downside)
Blogger Sentiment
Bullish
MX:COR Sentiment 70%
Sector Average 65%
Sector Average 65%
Insider Transactions
Bought Shares
Worth $40.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.49%
12-Months-Change
Fundamentals
Return on Equity
0.75%
Trailing 12-Months
Asset Growth
14.69%
Trailing 12-Months
Company Description
Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
COR Company Deck
COR Earnings Call
Q2 2026
0:00 / 0:00
COR Revenue Breakdown
90.55% U.S. Healthcare Solutions
9.45% International Healthcare Solutions
>-0.01% Intersegment eliminations

COR Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$6,106.69